HIV News and Research

RSS

Drug registration process for Nutra Pharma's pain reliever begins

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.

22 Sep 2009

CGI commitment to Action improves health services in Rwanda and Haiti

Management Sciences for Health (MSH) today reported that the first year of its four-year $12.5 million CGI Commitment to Action to introduce and expand Performance-Based Financing (PBF) has resulted in dramatically improved quality and delivery of health services for millions of people in Rwanda and Haiti. PBF empowers health managers to allocate resources in a way that rewards meeting health goals. By improving financial management capacity and expertise, PBF strengthens the sustainability and performance of ministries of health, district and community institutions, and NGOs.

22 Sep 2009

"Help is Here Express" bus tour in South Carolina to provide prescription medicines for free

The "Help is Here Express" bus tour will be stopping in South Carolina throughout the week of September 21 - 25 at various cities in order to help uninsured and financially struggling South Carolinians access information on programs that provide prescription medicines for free or nearly free. With the state's unemployment rate now hitting 11.8 percent, the Partnership for Prescription Assistance (PPA) bus tour is raising awareness of patient assistance programs among state residents who face layoffs and loss of health care benefits.

22 Sep 2009

Antigen to block infection by genetically-diverse strains of HIV

Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding.

22 Sep 2009

President Obama silent on the creation of a Global Fund for Education: Global AIDS Alliance

One year ago, on September 28, 2008, then-Candidate Barack Obama used the world stage provided by the annual meeting of the Clinton Global Initiative to promise that, if elected, he would work to create a Global Fund for Education.

22 Sep 2009

GeoVax requests FDA meeting to discuss IND for its therapeutic HIV/AIDS vaccine

GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss a proposed IND for GeoVax's therapeutic vaccine as a treatment for individuals infected with HIV/AIDS.

22 Sep 2009

AHF’s first AIDS treatment center to open in Washington, DC

AIDS Healthcare Foundation (AHF), the US’ largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening of AHF’s first AIDS treatment center in Washington, DC, where the HIV rate is now reported to be 3%—higher than the rate in Lagos, Nigeria. The health care center, AHF’s first to be named in honor of Hollywood actor and longtime AIDS advocate Blair Underwood, will include a state-of-the-art, full-service HIV/AIDS treatment clinic as well as an on-site AHF Pharmacy. The facility will be known as the AHF Blair Underwood Clinic.

22 Sep 2009

IRIN examines HIV/AIDS advocates' reaction to U.N. agency for women

IRIN examines how a recent resolution to create an agency to promote women's "rights and wellbeing" by the U.N. General Assembly is being welcomed by international HIV/AIDS advocates. According to IRIN, "[w]omen make up 60 percent of people living with AIDS in sub-Saharan Africa, a figure that rises to 75 percent in the 15-24 age range. In Asia, nearly 50 million women are at risk of becoming infected with HIV from their partners."

21 Sep 2009

Also in Global Health news: HIV/aids in Zambia; Ugandan medical workers; Obama administration officials' Q&A, speech; South African health care reform efforts; texting to combat drug shortages in Africa

The Post of Zambia examines the findings of a recent report revealing "the devastating effects" the HIV/AIDS epidemic in Zambia is having on the country's ability to meet the U.N. Millennium Development Goals. The article also looks at the relationship between HIV/AIDS and nutrition, maternal health and education (Chackwe, 9/21).

21 Sep 2009

Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reported today that it has signed a “Master Service Agreement” with the Southern Research Institute (“Southern Research”), Birmingham, AL. Southern Research is a well established, prestigious institution that has performed preclinical testing services for several vaccines and antivirals.

21 Sep 2009

TIME examines voluntary airline tax that aims to fund global health projects

TIME examines a voluntary airline tax, to be introduced in the U.S. and several European countries in January, that aims to "make up a shortfall in official government aid to poor countries — a shortfall exacerbated by the world financial crisis." The tax will be used to combat HIV/AIDS, tuberculosis and malaria, and it will also go towards improving maternal health and reducing child mortality.

21 Sep 2009

Hypertension Diagnostics' revenue decreases by 9.2% for the fiscal year 2009

Hypertension Diagnostics, Inc. (OTCBB: HDII), today announced audited financial results for the fiscal year ended June 30, 2009.

21 Sep 2009

Abbott Prism HIV O Plus assay approved by FDA

The U. S. Food and Drug Administration today announced approval of the Abbott Prism HIV O Plus assay, as a screening tool designed to detect the presence of certain antibodies to HIV. The assay is one of five assays that run on the fully automated Abbott Prism System.

21 Sep 2009

HIV mutates itself to escape antibodies

A study of how HIV mutates in response to immune system pressure by Emory Vaccine Center researchers shows that the virus can take several escape routes, not one preferred route.

21 Sep 2009

My Insurance Expert in support of the AIDS Walk Detroit 2009

My Insurance Expert, one of the nation leading online services to compare and secure affordable health insurance, is supporting AIDS Walk Detroit 2009 with a corporate donation and encouraging employees and friends to participate in the annual fund-raiser.

19 Sep 2009

Rwanda to receive second shipment of AIDS drug

Apotex Inc. today announced that the second shipment of Apo-TriAvir, the generic triple-combination AIDS drug produced to simplify AIDS treatment in developing countries, was leaving for Rwanda, the only country to have benefited from Canada's Access to Medicines Regime (CAMR).

19 Sep 2009

National Institutes of Health funds for thymus research

The National Institutes of Health have awarded, as part of the American Reinvestment and Recovery Act, a two-year, $2 million grant to a University of Georgia genetics researcher and her colleagues for studies on the thymus, the organ in humans that produces disease-fighting T-cells.

18 Sep 2009

Study reveals that older widowers are likely to be diagnosed with a STD

Widowers take care: Older men who have recently lost their wives are more likely than still-married peers to be diagnosed with a sexually transmitted disease (STD), according to a new study.

18 Sep 2009

Also in global health news: HIV/AIDS in Bangladesh; river blindness in Tanzania; potential immune system booster; compounds might fight TB

BDNews24.com reports on a new $13 million U.S.-government initiative aimed at "providing HIV-prevention services to two million at-risk people in Bangladesh including injecting drug users, male, female and transgender sex workers and their clients, and HIV-positive people through a network of 50 health centres." USAID will partner with Family Health International (FHI) to implement the program (9/17).

18 Sep 2009

President Obama's commitment to global AIDS and health is in doubt: GAA

Later today, Ambassador Eric Goosby will be sworn in as the U.S. Global AIDS Coordinator. "While we welcome Ambassador Goosby to his new post, and look forward to working with him on a broad range of issues that affect the health and well-being of the world's vulnerable populations, there are a number of as-yet unanswered questions about the true commitment of the Obama Administration to global AIDS and health, including PEPFAR [President's Emergency Plan for AIDS Relief]," said Dr. Paul Zeitz, GAA executive director.

18 Sep 2009